SG11202008186RA - Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates - Google Patents
Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonatesInfo
- Publication number
- SG11202008186RA SG11202008186RA SG11202008186RA SG11202008186RA SG11202008186RA SG 11202008186R A SG11202008186R A SG 11202008186RA SG 11202008186R A SG11202008186R A SG 11202008186RA SG 11202008186R A SG11202008186R A SG 11202008186RA SG 11202008186R A SG11202008186R A SG 11202008186RA
- Authority
- SG
- Singapore
- Prior art keywords
- phosphonothiolates
- alkyne
- phosphonates
- conjugation
- alkene
- Prior art date
Links
- 150000001336 alkenes Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/68031—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being an auristatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18160384 | 2018-03-07 | ||
PCT/EP2019/055509 WO2019170710A2 (fr) | 2018-03-07 | 2019-03-06 | Conjugaison chimiosélective d'un thiol avec des alcène- ou alcyne-phosphonothiolates et -phosphonates |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202008186RA true SG11202008186RA (en) | 2020-09-29 |
Family
ID=61691626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202008186RA SG11202008186RA (en) | 2018-03-07 | 2019-03-06 | Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates |
Country Status (12)
Country | Link |
---|---|
US (1) | US20200390901A1 (fr) |
EP (1) | EP3762423A2 (fr) |
JP (1) | JP7429191B2 (fr) |
KR (1) | KR20200138750A (fr) |
CN (1) | CN112088168A (fr) |
AU (1) | AU2019232602A1 (fr) |
BR (1) | BR112020018093A2 (fr) |
CA (1) | CA3092286A1 (fr) |
IL (1) | IL276981B2 (fr) |
RU (1) | RU2020128767A (fr) |
SG (1) | SG11202008186RA (fr) |
WO (1) | WO2019170710A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4297794A2 (fr) | 2021-02-26 | 2024-01-03 | Forschungsverbund Berlin E.V. | Absorption cellulaire de grandes biomolécules permise par des additifs peptidiques de pénétration cellulaire réactifs à la surface cellulaire |
CN117545511A (zh) | 2021-04-23 | 2024-02-09 | 柏林合作研究学会 | 与不饱和磷(v)化合物的硫醇偶联 |
AU2022385379A1 (en) | 2021-11-09 | 2024-06-20 | Forschungsverbund Berlin E.V. | Conjugates comprising a phosphorus (v) and a drug moiety |
KR20240100415A (ko) | 2021-11-09 | 2024-07-01 | 투불리스 게엠베하 | 인(v) 및 캄프토테신 모이어티를 포함하는 접합체 |
WO2024003002A1 (fr) | 2022-06-27 | 2024-01-04 | Diaccurate | Dérivés d'indoles n-substitués et conjugués pour le traitement du cancer |
WO2024083953A1 (fr) | 2022-10-18 | 2024-04-25 | Tubulis Gmbh | Nouvel anticorps anti-tpbg et conjugués anticorps-médicament basés sur celui-ci, procédés thérapeutiques et utilisations dudit anticorps |
US20240190958A1 (en) | 2022-10-18 | 2024-06-13 | Tubulis Gmbh | Novel antibody drug conjugates with novel napi2b antibodies, therapeutic methods and uses thereof |
WO2024133845A1 (fr) | 2022-12-22 | 2024-06-27 | Tubulis Gmbh | Conjugués comprenant une fraction phosphore (v) et un médicament |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2535174A (en) | 1949-04-07 | 1950-12-26 | Us Rubber Co | Mercaptoethanephosphonates |
CH410942A (de) | 1957-06-05 | 1966-04-15 | Bayer Ag | Verfahren zur Herstellung von Phosphonsäurethiolestern |
DE1064512B (de) | 1958-03-26 | 1959-09-03 | Bayer Ag | Verfahren zur Herstellung von beta-Alkylmercaptovinylphosphon-saeurethiolestern |
DE1072245B (de) * | 1957-06-24 | 1959-12-31 | Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk | Verfahren zur Herstellung von Phosphonsäure-O-alkyl-thiolestern |
US3223754A (en) * | 1959-12-04 | 1965-12-14 | Bayer Ag | Alkyl mercapto alkyl esters of substituted phosphonic acids |
US3121662A (en) * | 1960-03-09 | 1964-02-18 | Bayer Ag | (thiono)-thiolphosphonic and-thiolphosphinic acid esters and a process for their production |
NL262130A (fr) * | 1960-03-09 | |||
GB917085A (en) | 1960-12-08 | 1963-01-30 | Bayer Ag | Phosphonic and thiophosphonic acid esters |
US3904710A (en) | 1971-08-19 | 1975-09-09 | Exxon Research Engineering Co | Pesticidal O,S{40 -dialkyl S-phenylthioalkyl dithiophosphates and preparation thereof |
EP0859841B1 (fr) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Banques de proteines/(poly)peptides |
DK1545613T3 (da) | 2002-07-31 | 2011-11-14 | Seattle Genetics Inc | Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom |
JP5388856B2 (ja) * | 2007-10-18 | 2014-01-15 | 片山化学工業株式会社 | 含リン化合物と含イオウ化合物の触媒 |
RU2625756C2 (ru) | 2011-03-11 | 2017-07-18 | В.Л. Гор Энд Ассошиейтс, Инк. | Усовершенствованные иммобилизованные биологические объекты |
WO2015169784A1 (fr) | 2014-05-09 | 2015-11-12 | Bayer Pharma Aktiengesellschaft | Procédé de conjugaison ciblée de peptides et de protéines par pontage c2 par paires d'acides aminés cystéine |
JP7217225B2 (ja) * | 2016-09-01 | 2023-02-02 | フォルシュングスフェアバント ベルリン エー.ベー. | アルケンホスホンアミデートまたはアルキンホスホンアミデートとの化学選択的チオールコンジュゲーション |
-
2019
- 2019-03-06 KR KR1020207028795A patent/KR20200138750A/ko not_active Application Discontinuation
- 2019-03-06 WO PCT/EP2019/055509 patent/WO2019170710A2/fr active Application Filing
- 2019-03-06 US US16/977,680 patent/US20200390901A1/en active Pending
- 2019-03-06 IL IL276981A patent/IL276981B2/en unknown
- 2019-03-06 CN CN201980030827.8A patent/CN112088168A/zh active Pending
- 2019-03-06 SG SG11202008186RA patent/SG11202008186RA/en unknown
- 2019-03-06 JP JP2020546359A patent/JP7429191B2/ja active Active
- 2019-03-06 EP EP19713707.8A patent/EP3762423A2/fr active Pending
- 2019-03-06 AU AU2019232602A patent/AU2019232602A1/en active Pending
- 2019-03-06 CA CA3092286A patent/CA3092286A1/fr active Pending
- 2019-03-06 BR BR112020018093-9A patent/BR112020018093A2/pt unknown
- 2019-03-06 RU RU2020128767A patent/RU2020128767A/ru unknown
Also Published As
Publication number | Publication date |
---|---|
WO2019170710A3 (fr) | 2019-10-24 |
IL276981B1 (en) | 2023-12-01 |
WO2019170710A2 (fr) | 2019-09-12 |
AU2019232602A1 (en) | 2020-09-17 |
IL276981A (en) | 2020-10-29 |
JP7429191B2 (ja) | 2024-02-07 |
IL276981B2 (en) | 2024-04-01 |
CN112088168A (zh) | 2020-12-15 |
RU2020128767A (ru) | 2022-04-07 |
JP2021516959A (ja) | 2021-07-15 |
BR112020018093A2 (pt) | 2020-12-22 |
US20200390901A1 (en) | 2020-12-17 |
EP3762423A2 (fr) | 2021-01-13 |
CA3092286A1 (fr) | 2019-09-12 |
KR20200138750A (ko) | 2020-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276981A (en) | Chemoselective couplings of thiol with alkene or alkyne-phosphonothiolates and phosphonates | |
GB201917374D0 (en) | Not published | |
GB201810376D0 (en) | Not published | |
GB201917968D0 (en) | Not published | |
GB201802297D0 (en) | Not published | |
GB201719557D0 (en) | Polypeptide | |
GB201907569D0 (en) | Not published | |
GB201820521D0 (en) | n | |
GB201917378D0 (en) | Not published | |
GB201917976D0 (en) | Not published | |
GB201815305D0 (en) | Not published | |
GB201918689D0 (en) | n | |
GB201701986D0 (en) | n | |
SG11202003137SA (en) | Conjugated-diene-based rubber | |
PL3602533T3 (pl) | Element świetlny | |
GB201701848D0 (en) | Reciever | |
GB201813378D0 (en) | n | |
SG11202003006YA (en) | Natural rubber | |
IL261895B (en) | Middle zero reference point | |
GB2560036B (en) | E-ear trumpet | |
GB201713261D0 (en) | Submarine | |
GB2562074B (en) | Tracheostomy Device | |
GB201705186D0 (en) | Fibre | |
GB201707846D0 (en) | Use | |
GB201803760D0 (en) | MME - minutes made easy |